Interestingly, these investigators [9] had also observed that EGFR expression in BRAF mutant melanoma cells was surprisingly detrimental to their proliferative capacity, and was only tolerated in the context of BRAF inhibition. The gene discussed is EGFR; the disease is melanoma.